19752745

Source:http://linkedlifedata.com/resource/pubmed/id/19752745

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003241, umls-concept:C0030705, umls-concept:C0111208, umls-concept:C0150312, umls-concept:C0205210, umls-concept:C0278883, umls-concept:C0332206, umls-concept:C0536940, umls-concept:C0871261, umls-concept:C1413787, umls-concept:C1704632, umls-concept:C1704858, umls-concept:C1706817, umls-concept:C1707520, umls-concept:C2825965, umls-concept:C2911692
pubmed:issue	8
pubmed:dateCreated	2009-12-18
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19752745-19074257
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9706083
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Blocking, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/CTAG1B protein, human, http://linkedlifedata.com/resource/pubmed/chemical/CTLA-4 Antigen, http://linkedlifedata.com/resource/pubmed/chemical/CTLA4 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulins, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/SILV protein, human, http://linkedlifedata.com/resource/pubmed/chemical/gp100 Melanoma Antigen, http://linkedlifedata.com/resource/pubmed/chemical/ipilimumab
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1537-4513
pubmed:author	pubmed-author:El-GamilMonaM, pubmed-author:GoffStephanie LSL, pubmed-author:RobbinsPaul FPF, pubmed-author:RosenbergSteven ASA
pubmed:issnType	Electronic
pubmed:volume	32
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	884-5
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:19752745-Antibodies, Blocking, pubmed-meshheading:19752745-Antibodies, Monoclonal, pubmed-meshheading:19752745-Antibody Formation, pubmed-meshheading:19752745-Antigens, CD, pubmed-meshheading:19752745-Antigens, Neoplasm, pubmed-meshheading:19752745-CTLA-4 Antigen, pubmed-meshheading:19752745-Clinical Trials as Topic, pubmed-meshheading:19752745-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:19752745-Humans, pubmed-meshheading:19752745-Immunoglobulins, pubmed-meshheading:19752745-Melanoma, pubmed-meshheading:19752745-Membrane Glycoproteins, pubmed-meshheading:19752745-Membrane Proteins, pubmed-meshheading:19752745-Neoplasm Metastasis, pubmed-meshheading:19752745-Peptide Fragments, pubmed-meshheading:19752745-gp100 Melanoma Antigen
pubmed:year	2009
pubmed:articleTitle	No correlation between clinical response to CTLA-4 blockade and presence of NY-ESO-1 antibody in patients with metastatic melanoma.
pubmed:publicationType	Letter, Comment